Taken together, our results portray 2XmAbs as an enhancer of the effects induced by various TKIs on viability, apoptosis, and growth arrest of NSCLC cells expressing single‐site EGFR mutants (T790WT). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.